Cyteir Therapeutics (CYT)
NASDAQ:CYT
US Market
Holding CYT?
Track your performance easily

Cyteir Therapeutics (CYT) Cash flow

24 Followers

Cyteir Therapeutics Cash Flow

CYT's free cash flow for Q3 2023 was $-4.56M. For the 2023 fiscal year, CYT's free cash flow was decreased by $-5.64M and operating cash flow was $-4.56M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -25.75M$ -42.53M$ -36.01M$ -18.54M$ -17.56M
Investing Cash Flow
$ 303.00K$ -312.00K$ -1.19M$ -850.00K$ -133.00K
Financing Cash Flow
$ 842.00K$ 242.00K$ 216.01M$ 1.43M$ 36.89M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 548.12M$ 147.41M$ 190.00M$ 11.19M$ 29.16M
Income Tax Paid Supplemental Data
-----
Interest Paid Supplemental Data
-----
Issuance Of Capital Stock
$ 92.00K$ 64.00K$ 136.12M$ 0.00$ 36.62M
Issuance Of Debt
-----
Repayment Of Debt
-----
Free Cash Flow
$ -25.45M$ -42.84M$ -37.20M$ -19.39M$ -17.69M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

Cyteir Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis